Shanghai Pharmaceuticals (2607 HK) - Recent surge in share price makes us wary - Avoid the deal
Temasek plans to sell US$80m dollars worth of Shanghai Pharmaceutical shares, or about half of its current holding. We would avoid the deal...
369 Views
Opening of E-commerce Channel to Change China's Drug Market
Numerous press outlets report that China’s Food & Drug Administration (CFDA) will release regulations permitting online sales of...
352 Views
Introducing Long Term Leaders - Focussed Insights for your Core Holdings
We are pleased to announce the roll out of our latest content vertical: Long Term Leaders. Under this category, we have identified companies that...
309 Views